Drug Topics

DECEMBER 11, 2024

Ethan Melillo, PharmD, CDOE, senior manager of Integrated Health at LOral, provides some of his favorite recommendations to help with irritated skin.

466

466

STAT

DECEMBER 11, 2024

Gilead said Tuesday that it will soon begin Phase 3 testing for a drug it believes could prevent HIV infection with just a single shot every year. Such a medicine, if proven effective, would be the closest thing to a vaccine the HIV field has produced in four decades of research. The company plans to begin the trial next year, with an eye toward regulatory filings in late 2027.

Vaccines 145

Vaccines 145

Drug Topics

DECEMBER 11, 2024

Lisa Faast, PharmD, discusses how to use technology to innovate within the pharmacy.

247

247

STAT

DECEMBER 11, 2024

A proposed Senate bill that would prohibit companies that control health insurers or pharmacy benefit managers from owning pharmacies rattled investors on Wednesday, but some Wall Street analysts believe the legislation is unlikely to gain much traction, at least for now. The bipartisan bill , which would require divestiture within three years, is aimed at what the lawmakers call an “inherent conflict of interest” that has forced Americans to pay more for medicines and hastened the

Insurance 132

Insurance Independent Pharmacies 132

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

DECEMBER 11, 2024

Research found that SGLT2 inhibitors were associated with a lower risk of major cardiovascular events or hospitalization for heart failure.

Hospitals 247

Hospitals 247

STAT

DECEMBER 11, 2024

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far, so we are determined to hang on for another couple of days. And why not? The alternatives — at least those we can identify — are not so appetizing. And what better way to make the time fly than to keep busy.

Insurance 114

Insurance 114

PharmaVoice

DECEMBER 11, 2024

The agency has yet to make a decision about keeping tirzepatide on or off of its shortage list — letting compound pharmacies continue their lucrative operations for now.

Compounding 162

Compounding Compounding Pharmacies FDA 162

Drug Topics

DECEMBER 11, 2024

Whether due to jet lag, stress, major life events, or something else, there are a lot of issues that can cause short-term insomnia. Send patients on their way to a better nights sleep with these OTC sleep aid recommendations.

247

247

STAT

DECEMBER 11, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning, hope everyone is staying warm this week wherever you are. Here in Chicago, we’re expecting an Arctic blast to hit this afternoon, which is karma for me saying how much I missed this city while I was gone.

111

111

Drug Topics

DECEMBER 11, 2024

Denise Kelley, PharmD, BCPS, FASHP, discussed the efficacy of medications designed to treat the progression of chronic kidney disease.

247

247

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

DECEMBER 11, 2024

The combination vaccine candidates will be evaluated in 2 separate phase 1/2 clinical trials.

Vaccines 139

Vaccines FDA 139

Drug Topics

DECEMBER 11, 2024

John Bucheit, PharmD, joined Drug Topics to discuss statins and nonstatins efficacy in treating cardiovascular disease.

247

247

Pharmacy Times

DECEMBER 11, 2024

According to the report, 75% of survey participants expect pharmacists to oversee these therapies and 58% expect Medicare will require pharmacist involvement.

139

139

Drug Topics

DECEMBER 11, 2024

Kathryn Litten, PharmD, joined Drug Topics to discuss how pharmacists can counsel patients with metabolic dysfunction-associated steatotic liver disease.

247

247

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

DECEMBER 11, 2024

Experts highlight the importance of dosing and regimen optimization in breast cancer to improve treatment tolerability, reduce toxicities, and improve quality of life for patients.

132

132

Drug Topics

DECEMBER 11, 2024

A conversation with Kathleen Vest, PharmD, BCACP, CDCES, FCCP, professor of Pharmacy Practice at Drake University College of Pharmacy and Health Sciences.

190

190

Pharmacy Times

DECEMBER 11, 2024

Assessing pre-treatment TIL levels in young breast cancer patients could help predict response to neoadjuvant chemotherapy.

Immunization 130

Immunization Chemotherapy 130

European Pharmaceutical Review

DECEMBER 11, 2024

LOG Pharma Primary Packaging is set to present its new barrier eco line at Pharmapack Europe 2025. The new bottles for pharmaceuticals offer optimal oxygen scavenging. Our R&D team has developed a series of barrier bottles that provide exceptional protection against oxygen and moisture while being environmentally friendly and reducing costs significantly, stated LOGs Chief Executive Officer Shaul Bassi.

Packaging 105

Packaging 105

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

DECEMBER 11, 2024

Both risk-reducing mastectomy and salpingo-oophorectomy were associated with significant improvements among young BRCA carriers with breast cancer.

123

123

Pharmaceutical Technology

DECEMBER 11, 2024

When a room of physicians at ASH 2024 was asked whether they had prescribed a gene therapy in a commercial context, only a handful said yes.

105

105

Pharmacy Times

DECEMBER 11, 2024

Rural patients face significant barriers to health care access and affordability that contribute to poor hypertension management.

122

122

PharmaVoice

DECEMBER 11, 2024

Despite the disease’s prevalence, endometriosis remains misunderstood, and research into drugs that might treat it draws scant funding — problems that have deep roots.

100

100

Pharmacy Times

DECEMBER 11, 2024

At the 2024 San Antonio Breast Cancer Symposium, experts discussed the development, clinical impact, and challenges of antibody-drug conjugates (ADCs).

121

121

Fierce Healthcare

DECEMBER 11, 2024

| HighRoads CEO Brian Kim discusses growing benefit plan complexity, the need for automation to reduce costs and AI's potential in healthcare management.

81

81

Pharmacy Times

DECEMBER 11, 2024

Komal Jhaveri MD, FACP, shares that the combination of imlunestrant plus abemaciclib further improved progression-free survival compared to imlunestrant alone.

121

121

Pharmaceutical Technology

DECEMBER 11, 2024

Er-Kim has extended its exclusive agreement with Ascendis Pharma for endocrinology treatments across multiple countries in Eurasia.

69

69

Pharmacy Times

DECEMBER 11, 2024

Dose rounding within an acceptable range can provide cost savings and minimize waste, but requires careful interprofessional collaboration and patient education.

65

65

Pharmaceutical Technology

DECEMBER 11, 2024

The push to replace Albert Bourla as Pfizers CEO drew attention from the pharma industry but was soon derailed by several events.

59

59

Pharmacy Times

DECEMBER 11, 2024

Virginia Kaklamani, MD, DSc, shares the role of ESR1 mutation testing and combination strategies to optimize endocrine therapy in patients with metastatic HR+/HER2- breast cancer.

65

65

Pharmaceutical Technology

DECEMBER 11, 2024

If accepted, Vifor Pharma's 23m offer will "claw back" money for the NHS and close the CMA's first-ever disparagement case.

59

59

Pharma Times

DECEMBER 11, 2024

Promising results set stage for European marketing authorization

54

54

Pharmaceutical Technology

DECEMBER 11, 2024

Relation has announced two strategic collaborations with GSK, focusing on new therapeutics for fibrotic and osteoarthritis.

59

59

Pharma Times

DECEMBER 11, 2024

Successful phase 1 study highlights potential of roginolisib

54

54